Integrated Filing — IndAS



General information about company

Scrip Code 512529
NSE Symbol SEQUENT
MSEI Symbol NA
ISIN INE807F01027
Name of company Sequent Scientific limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 14-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 03-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 14-11-2025   19:30:00
End date and time of board meeting 14-11-2025   20:26:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 11-02-2025
Indicate Company website link for updated RPT policy of the Company https://sequent.in/wp-content/uploads/2025/02/5.-Related-Party-Transactions.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 3,403.00 7,510.00
Other income 1,175.00 2,323.00
Total income 4,578.00 9,833.00
2 Expenses
(a) Cost of materials consumed 1,680.00 3,656.00
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (126.00) 46.00
(d) Employee benefit expense 946.00 1,894.00
(e) Finance costs 83.00 191.00
(f) Depreciation, depletion and amortisation expense 224.00 457.00
(f) Other Expenses
1 Conversion and processing charges 4.00 61.00
2 Other expenses 1,163.00 2,321.00
Total other expenses 1,167.00 2,382.00
Total expenses 3,974.00 8,626.00
3 Total profit before exceptional items and tax 604.00 1,207.00
4 Exceptional items (170.00) (295.00)
5 Total profit before tax 434.00 912.00
6 Tax expense
7 Current tax 225.00 309.00
8 Deferred tax (99.00) (42.00)
9 Total tax expenses 126.00 267.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 308.00 645.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 308.00 645.00
17 Other comprehensive income net of taxes 7.00 7.00
18 Total Comprehensive Income for the period 315.00 652.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 5,033.00 5,033.00
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.12 0.26
Diluted earnings (loss) per share from continuing operations 0.12 0.25
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.12 0.26
Diluted earnings (loss) per share from continuing and discontinued operations 0.12 0.25
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 4,581.00
Capital work-in-progress 92.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 73.00
Intangible assets under development 26.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 65,312.00
Trade receivables, non-current 0.00
Loans, non-current 42,968.00
Other non-current financial assets 283.00
Total non-current financial assets 1,08,563.00
Deferred tax assets (net) 1,009.00
Other non-current assets 601.00
Total non-current assets 1,14,945.00
2 Current assets
Inventories 2,619.00
Current financial asset
Current investments 7.00
Trade receivables, current 4,949.00
Cash and cash equivalents 75.00
Bank balance other than cash and cash equivalents 2.00
Loans, current 6.00
Other current financial assets 37.00
Total current financial assets 5,076.00
Current tax assets (net)
Other current assets 625.00
Total current assets 8,320.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1,23,265.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 5,033.00
Other equity 1,13,088.00
Total equity attributable to owners of parent 1,18,121.00
Non controlling interest
Total equity 1,18,121.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 0.00
Total non-current financial liabilities 0.00
Provisions, non-current 243.00
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities 44.00
Total non-current liabilities 287.00
Current liabilities
Current financial liabilities
Borrowings, current 2,264.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 686.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1,132.00
Total Trade payable 1,818.00
Other current financial liabilities 347.00
Total current financial liabilities 4,429.00
Other current liabilities 367.00
Provisions, current 61.00
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 4,857.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 5,144.00
Total equity and liabilites 1,23,265.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 (a) Re-measurement gain / (loss) on defined benefits plans 1200000 1200000
2 (b) Fair value gain / (loss) from investment in equity instruments -200000 -200000
Total Amount of items that will not be reclassified to profit and loss 10.00 10.00
2 Income tax relating to items that will not be reclassified to profit or loss 3.00 3.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 7.00 7.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 912.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 191.00
Adjustments for decrease (increase) in inventories (114.00)
Adjustments for decrease (increase) in trade receivables, current 3,329.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (429.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 457.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 22.00
Adjustments for dividend income 0.00
Adjustments for interest income 1,925.00
Adjustments for share-based payments 634.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 1.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 62.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 2,228.00
Net cash flows from (used in) operations 3,140.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 223.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 2,917.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 26.00
Purchase of property, plant and equipment 175.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 1,750.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 201.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 35.00
Net cash flows from (used in) investing activities (1,663.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 1,199.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 2,174.00
Payments of lease liabilities 27.00
Dividends paid 0.00
Interest paid 180.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (1,182.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 72.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 72.00
Cash and cash equivalents cash flow statement at beginning of period 3.00
Cash and cash equivalents cash flow statement at end of period 75.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results No
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 SRBC & Co. LLP Yes 28-02-2026


Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Alivira Animal Health Limited, India Sequent Research Limited, India Fellow Subsidiary Any other transaction Analytical charges 444.20 NA 444.20 0.00 0.00
2 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Analytical charges 27.50 NA 27.50 0.00 0.00
3 Sequent Scientific Limited, India Sequent Research Limited, India Wholly owned subsidiary Any other transaction Analytical charges 29.60 NA 29.60 0.00 0.00
4 Fendigo SA, Belgium Fendigo BV, Netherland Fellow Subsidiary Any other transaction Commission expenses 668.70 NA 668.70 0.00 0.00
5 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction cost of sales 1,477.80 NA 1,477.80 0.00 0.00
6 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction cost of sales 457.70 NA 457.70 0.00 0.00
7 Sequent Research Limited, India Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Support service charges 7.90 NA 7.90 0.00 0.00
8 Sequent Research Limited, India Sequent Scientific Limited, India Holding Any other transaction Support service charges 7.20 NA 7.20 0.00 0.00
9 Fendigo BV, Netherland Fendigo SA, Belgium Fellow Subsidiary Any other transaction Freight and forwarding 54.70 NA 54.70 0.00 0.00
10 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Freight and forwarding 8.40 NA 8.40 0.00 0.00
11 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Freight and forwarding 8.30 NA 8.30 0.00 0.00
12 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Miscellaneous Income 91.20 NA 91.20 0.00 0.00
13 Alivira Animal Health Limited, India Sequent Research Limited, India Fellow Subsidiary Any other transaction Miscellaneous Income 7.90 NA 7.90 0.00 0.00
14 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Miscellaneous Income 310.20 NA 310.20 0.00 0.00
15 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Miscellaneous Income 328.00 NA 328.00 0.00 0.00
16 Sequent Scientific Limited, India Alivira Animal Health Limited, Ireland Step down subsidiary Any other transaction Miscellaneous Income 27.50 NA 27.50 0.00 0.00
17 Sequent Scientific Limited, India Sequent Research Limited, India Wholly owned subsidiary Any other transaction Miscellaneous Income 7.20 NA 7.20 0.00 0.00
18 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction other boorrowing cost 95.00 NA 95.00 0.00 0.00
19 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction other boorrowing cost 10.00 NA 10.00 0.00 0.00
20 Alivira Animal Health Limited, Ireland Sequent Scientific Limited, India Ultimate Holding company Any other transaction other boorrowing cost 27.10 NA 27.10 0.00 0.00
21 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction other boorrowing cost 19.00 NA 19.00 0.00 0.00
22 Alivira Saude Animal Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Other Expenses 6.00 NA 6.00 0.00 0.00
23 Alivira Saude Animal Brasil Participacoes Ltda Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Other Expenses 10.90 NA 10.90 0.00 0.00
24 Fendigo BV, Netherland Fendigo SA, Belgium Fellow Subsidiary Any other transaction Other Expenses 12.50 NA 12.50 0.00 0.00
25 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Other Expenses 81.00 NA 81.00 0.00 0.00
26 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction other income 40.40 NA 40.40 0.00 0.00
27 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction other income 68.10 NA 68.10 0.00 0.00
28 Alivira Animal Health Limited, Ireland Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Step down subsidiary Any other transaction other income 10.40 NA 10.40 0.00 0.00
29 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Any other transaction other income 10.40 NA 10.40 0.00 0.00
30 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction other income 82.00 NA 82.00 0.00 0.00
31 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction other income 50.70 NA 50.70 0.00 0.00
32 Fendigo SA, Belgium Fendigo BV, Netherland Fellow Subsidiary Any other transaction other income 77.60 NA 77.60 0.00 0.00
33 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Any other transaction other income 11.50 NA 11.50 0.00 0.00
34 Fendigo BV, Netherland Fendigo SA, Belgium Fellow Subsidiary Any other transaction Miscellaneous Income 668.70 NA 668.70 0.00 0.00
35 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Miscellaneous Income 254.40 NA 254.40 0.00 0.00
36 Laboratorios Karizoo, S.A., Spain Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Any other transaction Miscellaneous Income 44.30 NA 44.30 0.00 0.00
37 Laboratorios Karizoo, S.A., Spain Alivira Saude Animal Brasil Participacoes Ltda Fellow Subsidiary Any other transaction Miscellaneous Income 11.10 NA 11.10 0.00 0.00
38 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow Subsidiary Any other transaction Miscellaneous Income 5.60 NA 5.60 0.00 0.00
39 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Subsidiary Any other transaction Miscellaneous Income 59.80 NA 59.80 0.00 0.00
40 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow Subsidiary Any other transaction Miscellaneous Income 85.50 NA 85.50 0.00 0.00
41 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Miscellaneous Income 271.70 NA 271.70 0.00 0.00
42 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Miscellaneous Income 1,604.10 NA 1,604.10 0.00 0.00
43 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Miscellaneous Income 457.70 NA 457.70 0.00 0.00
44 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Professional fees 40.40 NA 40.40 0.00 0.00
45 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Professional fees 176.70 NA 176.70 0.00 0.00
46 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Professional fees 79.70 NA 79.70 0.00 0.00
47 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Any other transaction Professional fees 113.70 NA 113.70 0.00 0.00
48 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Professional fees 255.70 NA 255.70 0.00 0.00
49 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Professional fees 67.00 NA 67.00 0.00 0.00
50 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Professional fees 35.00 NA 35.00 0.00 0.00
51 Alivira Saude Animal Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Professional fees 38.60 NA 38.60 0.00 0.00
52 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Professional fees 5.60 NA 5.60 0.00 0.00
53 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Professional fees 10.20 NA 10.20 0.00 0.00
54 Fendigo SA, Belgium Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Professional fees 58.70 NA 58.70 0.00 0.00
55 Fendigo BV, Netherland Fendigo SA, Belgium Fellow Subsidiary Any other transaction Professional fees 10.40 NA 10.40 0.00 0.00
56 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Holding Any other transaction Professional fees 59.80 NA 59.80 0.00 0.00
57 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Professional fees 133.80 NA 133.80 0.00 0.00
58 N-Vet AB, Sweden Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Professional fees 12.10 NA 12.10 0.00 0.00
59 Phytotherapic Solutions S.L., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Professional fees 15.50 NA 15.50 0.00 0.00
60 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Professional fees 38.90 NA 38.90 0.00 0.00
61 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Professional fees 53.50 NA 53.50 0.00 0.00
62 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Professional fees 291.20 NA 291.20 0.00 0.00
63 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Professional fees 19.40 NA 19.40 0.00 0.00
64 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Professional fees 24.20 NA 24.20 0.00 0.00
65 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Professional fees 42.20 NA 42.20 0.00 0.00
66 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Research & Development expenses 238.40 NA 238.40 0.00 0.00
67 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Research & Development expenses 246.40 NA 246.40 0.00 0.00
68 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Rent 56.30 NA 56.30 0.00 0.00
69 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Rent 6.30 NA 6.30 0.00 0.00
70 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Other oprating income 112.70 NA 112.70 0.00 0.00
71 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Travel expenses 78.40 NA 78.40 0.00 0.00
72 Sequent Scientific Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Rent 0.60 NA 0.60 0.00 0.00
73 Sequent Scientific Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Rent 0.60 NA 0.60 0.00 0.00
74 Alivira Animal Health Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Miscellaneous Income 44.30 NA 44.30 0.00 0.00
75 Alivira Animal Health Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Miscellaneous Income 44.30 NA 44.30 0.00 0.00
76 Sequent Research Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Rent 1.20 NA 1.20 0.00 0.00
77 Viyash Life Sciences Private Limited Sequent Scientific Limited, India Other related party Any other transaction other income 0.60 NA 0.60 0.00 0.00
78 Viyash Life Sciences Private Limited Sequent Scientific Limited, India Other related party Any other transaction other income 0.60 NA 0.60 0.00 0.00
79 Viyash Life Sciences Private Limited Alivira Animal Health Limited, India Other related party Any other transaction Research & Development expenses 44.30 NA 44.30 0.00 0.00
80 Viyash Life Sciences Private Limited Alivira Animal Health Limited, India Other related party Any other transaction Research & Development expenses 44.30 NA 44.30 0.00 0.00
81 Viyash Life Sciences Private Limited Sequent Research Limited, India Other related party Any other transaction other income 1.20 NA 1.20 0.00 0.00
82 Alivira Animal Health Limited, India Rajaram Narayanan Managing Director Any other transaction Remuneration 234.90 NA 234.90 0.00 0.00
83 Alivira Animal Health Limited, India Vedprakash Ragate Executive Director Any other transaction Remuneration 119.40 NA 119.40 0.00 0.00
84 Sequent Scientific Limited, India Rajaram Narayanan Managing Director Any other transaction Remuneration 112.60 NA 112.60 0.00 0.00
85 Sequent Scientific Limited, India Saurav Bhala Chief Financial Officer Any other transaction Remuneration 130.80 NA 130.80 0.00 0.00
86 Sequent Scientific Limited, India Dr Kamal Sharma Independent Directors Any other transaction Director sitting Fees 12.00 NA 12.00 0.00 0.00
87 Sequent Scientific Limited, India Milind Sarwate Independent Directors Any other transaction Director sitting Fees 12.00 NA 12.00 0.00 0.00
88 Sequent Scientific Limited, India Revati Kasture Independent Directors Any other transaction Director sitting Fees 4.00 NA 4.00 0.00 0.00
89 Sequent Scientific Limited, India Fabian Kausche Non- Executive Directors Any other transaction Director sitting Fees 3.00 NA 3.00 0.00 0.00
90 Sequent Scientific Limited, India Gregory Andrews Non- Executive Directors Any other transaction Director sitting Fees 4.00 NA 4.00 0.00 0.00
91 Sequent Scientific Limited, India Dr. Hari Babu Non- Executive Directors Any other transaction Director sitting Fees 4.00 NA 4.00 0.00 0.00
92 Sequent Scientific Limited, India Yoshita Susmit Vora Company Secretary Any other transaction Remuneration 14.40 NA 14.40 0.00 0.00
93 Alivira Animal Health Limited, India Dr Kamal Sharma Independent Directors Any other transaction Director sitting Fees 1.00 NA 1.00 0.00 0.00
94 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Dividend received 732.70 NA 732.70 0.00 0.00
95 Alivira Animal Health Limited, Ireland Vila Vina Participacions S.L., Spain Subsidiary Dividend received 363.20 NA 363.20 0.00 0.00
96 Alivira Saude Animal Brasil Participacoes Ltda Alivira Saude Animal Ltda, Brazil Wholly owned subsidiary Dividend received 18.50 NA 18.50 0.00 0.00
97 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Dividend received 398.00 NA 398.00 0.00 0.00
98 Vila Vina Participacions S.L., Spain Phytotherapic Solutions S.L., Spain Wholly owned subsidiary Dividend received 199.30 NA 199.30 0.00 0.00
99 Alivira Animal Health Limited, India Sequent Research Limited, India Fellow Subsidiary Interest paid 8.70 NA 8.70 0.00 0.00
100 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Interest paid 1,915.50 NA 1,915.50 0.00 0.00
101 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Interest paid 662.40 NA 662.40 0.00 0.00
102 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Interest paid 10.20 NA 10.20 0.00 0.00
103 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Interest paid 22.40 NA 22.40 0.00 0.00
104 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Fellow Subsidiary Interest paid 187.80 NA 187.80 0.00 0.00
105 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Interest paid 544.60 NA 544.60 0.00 0.00
106 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Interest paid 137.30 NA 137.30 0.00 0.00
107 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Interest paid 21.00 NA 21.00 0.00 0.00
108 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Interest paid 93.70 NA 93.70 0.00 0.00
109 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Ultimate Holding company Interest paid 138.40 NA 138.40 0.00 0.00
110 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Interest received 667.70 NA 667.70 0.00 0.00
111 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Interest received 188.60 NA 188.60 0.00 0.00
112 Alivira Animal Health Limited, Ireland Alivira Saude Animal Brasil Participacoes Ltda Wholly owned subsidiary Interest received 545.40 NA 545.40 0.00 0.00
113 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Interest received 137.50 NA 137.50 0.00 0.00
114 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Interest received 103.70 NA 103.70 0.00 0.00
115 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Interest received 127.20 NA 127.20 0.00 0.00
116 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Interest received 10.20 NA 10.20 0.00 0.00
117 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Interest received 22.40 NA 22.40 0.00 0.00
118 Sequent Research Limited, India Alivira Animal Health Limited, India Fellow Subsidiary Interest received 8.70 NA 8.70 0.00 0.00
119 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Interest received 1,915.50 NA 1,915.50 0.00 0.00
120 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Interest received 21.00 NA 21.00 0.00 0.00
121 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Purchase of goods or services 1,601.00 NA 1,601.00 0.00 0.00
122 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Purchase of goods or services 2,139.30 NA 2,139.30 0.00 0.00
123 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Purchase of goods or services 385.20 NA 385.20 0.00 0.00
124 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow Subsidiary Purchase of goods or services 54.20 NA 54.20 0.00 0.00
125 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Purchase of goods or services 3,022.40 NA 3,022.40 0.00 0.00
126 Fendigo SA, Belgium Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Purchase of goods or services 459.00 NA 459.00 0.00 0.00
127 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Purchase of goods or services 37.50 NA 37.50 0.00 0.00
128 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Purchase of goods or services 571.20 NA 571.20 0.00 0.00
129 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, India Fellow Subsidiary Purchase of goods or services 649.30 NA 649.30 0.00 0.00
130 Alivira Saude Animal Ltda, Brazil Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Purchase of goods or services 151.40 NA 151.40 0.00 0.00
131 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Purchase of goods or services 5.90 NA 5.90 0.00 0.00
132 Bremer Pharma GmbH, Germany Phytotherapic Solutions S.L., Spain Fellow Subsidiary Purchase of goods or services 20.60 NA 20.60 0.00 0.00
133 Laboratorios Karizoo S.A. de C.V.,Mexico Phytotherapic Solutions S.L., Spain Fellow Subsidiary Purchase of goods or services 231.90 NA 231.90 0.00 0.00
134 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow Subsidiary Purchase of goods or services 850.00 NA 850.00 0.00 0.00
135 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Purchase of goods or services 14.00 NA 14.00 0.00 0.00
136 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Purchase of goods or services 163.00 NA 163.00 0.00 0.00
137 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Fellow Subsidiary Purchase of goods or services 44.50 NA 44.50 0.00 0.00
138 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Purchase of goods or services 413.80 NA 413.80 0.00 0.00
139 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Purchase of goods or services 46.20 NA 46.20 0.00 0.00
140 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Purchase of goods or services 941.20 NA 941.20 0.00 0.00
141 Alivira Animal Health Limited, India Symed Labs Limited Other related party Purchase of goods or services 292.80 NA 292.80 0.00 0.00
142 Alivira Animal Health Limited, India Viyash Life Sciences Private Limited Other related party Purchase of goods or services 40.70 NA 40.70 0.00 0.00
143 Symed Labs Limited Alivira Animal Health Limited, India Other related party Purchase of goods or services 6.10 NA 6.10 0.00 0.00
144 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Sale of goods or services 2,151.20 NA 2,151.20 0.00 0.00
145 Alivira Animal Health Limited, India Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Sale of goods or services 588.20 NA 588.20 0.00 0.00
146 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Sale of goods or services 46.60 NA 46.60 0.00 0.00
147 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Sale of goods or services 46.20 NA 46.20 0.00 0.00
148 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow Subsidiary Sale of goods or services 82.90 NA 82.90 0.00 0.00
149 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow Subsidiary Sale of goods or services 3,022.40 NA 3,022.40 0.00 0.00
150 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow Subsidiary Sale of goods or services 420.20 NA 420.20 0.00 0.00
151 Laboratorios Karizoo, S.A., Spain Fendigo SA, Belgium Fellow Subsidiary Sale of goods or services 517.70 NA 517.70 0.00 0.00
152 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow Subsidiary Sale of goods or services 74.40 NA 74.40 0.00 0.00
153 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow Subsidiary Sale of goods or services (28.70) NA (28.70) 0.00 0.00
154 Phytotherapic Solutions S.L., Spain Bremer Pharma GmbH, Germany Fellow Subsidiary Sale of goods or services 20.60 NA 20.60 0.00 0.00
155 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow Subsidiary Sale of goods or services 231.90 NA 231.90 0.00 0.00
156 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Sale of goods or services 850.00 NA 850.00 0.00 0.00
157 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Fellow Subsidiary Sale of goods or services 39.50 NA 39.50 0.00 0.00
158 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Sale of goods or services 169.00 NA 169.00 0.00 0.00
159 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Sale of goods or services 15.50 NA 15.50 0.00 0.00
160 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Sale of goods or services 944.30 NA 944.30 0.00 0.00
161 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Sale of goods or services 2,172.20 NA 2,172.20 0.00 0.00
162 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Sale of goods or services 412.50 NA 412.50 0.00 0.00
163 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Sale of goods or services 241.20 NA 241.20 0.00 0.00
164 Laboratorios Karizoo, S.A., Spain N-Vet AB, Sweden Fellow Subsidiary Sale of goods or services 12.20 NA 12.20 0.00 0.00
165 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow Subsidiary Sale of goods or services 33.50 NA 33.50 0.00 0.00
166 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Sale of goods or services 49.60 NA 49.60 0.00 0.00
167 Laboratorios Karizoo, S.A., Spain Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Fellow Subsidiary Sale of goods or services 21.50 NA 21.50 0.00 0.00
168 Sequent Research Limited, India Alivira Animal Health Limited, India Fellow Subsidiary Sale of goods or services 444.20 NA 444.20 0.00 0.00
169 Sequent Research Limited, India Sequent Scientific Limited, India Holding Sale of goods or services 29.60 NA 29.60 0.00 0.00
170 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Sale of goods or services 128.60 NA 128.60 0.00 0.00
171 Vila Vina Participacions S.L., Spain Phytotherapic Solutions S.L., Spain Wholly owned subsidiary Sale of goods or services 15.50 NA 15.50 0.00 0.00
172 Alivira Animal Health Limited, India Symed Labs Limited Other related party Sale of goods or services 6.10 NA 6.10 0.00 0.00
173 Symed Labs Limited Alivira Animal Health Limited, India Other related party Sale of goods or services 292.80 NA 292.80 0.00 0.00
174 Viyash Life Sciences Private Limited Alivira Animal Health Limited, India Other related party Sale of goods or services 40.70 NA 40.70 0.00 0.00
175 Alivira Saude Animal Ltda, Brazil Alivira Saude Animal Brasil Participacoes Ltda Holding Dividend paid 19.80 NA 19.80 0.00 0.00
176 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Dividend paid 781.70 NA 781.70 0.00 0.00
177 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Dividend paid 0.40 NA 0.40 0.00 0.00
178 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Dividend paid 416.30 NA 416.30 0.00 0.00
179 Phytotherapic Solutions S.L., Spain Vila Vina Participacions S.L., Spain Holding Dividend paid 208.40 NA 208.40 0.00 0.00
180 Vila Vina Participacions S.L., Spain Alivira Animal Health Limited, Ireland Holding Dividend paid 375.20 NA 375.20 0.00 0.00
181 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Any other transaction Loans and Advances NA 0.00 1,629.10 2,699.90
182 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow Subsidiary Any other transaction Advances from customers NA 0.00 1,629.10 2,699.90
183 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 5.00 5.10
184 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 38.40 61.50
185 Alivira Animal Health Limited, India Bremer Pharma GmbH, Germany Fellow Subsidiary Any other transaction Trade Payable NA 0.00 3.20 0.10
186 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 1.80 1.20
187 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Any other transaction Trade Payable NA 0.00 15.60 37.50
188 Alivira Animal Health Limited, India Sequent Research Limited, India Fellow Subsidiary Any other transaction Trade Payable NA 0.00 214.30 304.70
189 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Trade Payable NA 0.00 4,928.20 3,394.40
190 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Trade Payable NA 0.00 678.20 1,910.10
191 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 22.20 23.00
192 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 0.00 18.50
193 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Payable NA 0.00 99.50 231.60
194 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 551.80 648.10
195 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 386.20 276.20
196 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 28.50 27.30
197 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Trade Payable NA 0.00 390.90 622.20
198 Alivira Saude Animal Ltda, Brazil Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Any other transaction Trade Payable NA 0.00 0.00 64.20
199 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 0.00 2.70
200 Alivira Saude Animal Brasil Participacoes Ltda Alivira Saude Animal Ltda, Brazil Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 0.00 3.40
201 Alivira Saude Animal Brasil Participacoes Ltda Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 0.00 6.00
202 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 473.00 533.90
203 Bremer Pharma GmbH, Germany Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 75.50 91.10
204 Bremer Pharma GmbH, Germany Phytotherapic Solutions S.L., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 38.60 65.10
205 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Any other transaction Trade Payable NA 0.00 9.00 10.20
206 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 0.00 4.60
207 Fendigo SA, Belgium Fendigo BV, Netherland Fellow Subsidiary Any other transaction Trade Payable NA 0.00 61.80 103.60
208 Fendigo SA, Belgium Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 41.40 112.10
209 Fendigo BV, Netherland Fendigo SA, Belgium Fellow Subsidiary Any other transaction Trade Payable NA 0.00 31.10 13.80
210 Laboratorios Karizoo S.A. de C.V.,Mexico Laboratorios Karizoo, S.A., Spain Holding Any other transaction Trade Payable NA 0.00 120.20 192.10
211 Laboratorios Karizoo S.A. de C.V.,Mexico Phytotherapic Solutions S.L., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 300.40 583.20
212 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Trade Payable NA 0.00 60.60 84.70
213 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 233.50 364.00
214 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Any other transaction Trade Payable NA 0.00 33.00 11.20
215 N-Vet AB, Sweden Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 1.00 2.00
216 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow Subsidiary Any other transaction Trade Payable NA 0.00 3.70 30.00
217 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 43.10 198.00
218 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Trade Payable NA 0.00 0.00 19.90
219 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Payable NA 0.00 1,216.60 17.30
220 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow Subsidiary Any other transaction Trade Payable NA 0.00 360.60 408.80
221 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 84.00 55.20
222 Sequent Scientific Limited, India Sequent Research Limited, India Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 25.20 21.70
223 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Trade Payable NA 0.00 0.00 18.20
224 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 8.00 31.50
225 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 686.40 1,883.20
226 Alivira Animal Health Limited, India Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 393.80 588.20
227 Alivira Animal Health Limited, India Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 0.00 25.20
228 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Trade Receivable NA 0.00 38.50 63.20
229 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 547.40 595.60
230 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 427.40 443.40
231 Alivira Animal Health Limited, Ireland Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Step down subsidiary Any other transaction Trade Receivable NA 0.00 0.00 2.70
232 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 0.00 4.50
233 Alivira Animal Health Limited, Ireland Laboratorios Karizoo, S.A., Spain Step down subsidiary Any other transaction Trade Receivable NA 0.00 59.70 84.20
234 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 1,385.80 17.30
235 Alivira Italia S.R.L. Phytotherapic Solutions S.L., Spain Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 3.70 30.00
236 Alivira Saude Animal Ltda, Brazil Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 10.60 3.40
237 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 22.20 25.10
238 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 363.50 410.30
239 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 0.00 18.50
240 Fendigo SA, Belgium Fendigo BV, Netherland Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 31.10 13.80
241 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 0.00 13.10
242 Fendigo BV, Netherland Fendigo SA, Belgium Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 61.80 103.60
243 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 1.80 1.90
244 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Trade Receivable NA 0.00 102.40 234.00
245 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 386.20 276.20
246 Laboratorios Karizoo, S.A., Spain Alivira Saude Animal Brasil Participacoes Ltda Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 0.00 6.10
247 Laboratorios Karizoo, S.A., Spain Bremer Pharma GmbH, Germany Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 75.50 91.10
248 Laboratorios Karizoo, S.A., Spain Fendigo SA, Belgium Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 41.40 112.10
249 Laboratorios Karizoo, S.A., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Subsidiary Any other transaction Trade Receivable NA 0.00 120.40 192.10
250 Laboratorios Karizoo, S.A., Spain N-Vet AB, Sweden Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 1.00 2.00
251 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 43.10 198.00
252 Laboratorios Karizoo, S.A., Spain Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 84.70 55.40
253 Laboratorios Karizoo, S.A., Spain Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 8.10 31.60
254 Phytotherapic Solutions S.L., Spain Alivira Italia S.R.L. Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 28.50 27.30
255 Phytotherapic Solutions S.L., Spain Bremer Pharma GmbH, Germany Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 38.60 65.10
256 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 311.00 583.20
257 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 233.50 364.00
258 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 35.20 38.40
259 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 0.00 64.30
260 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 0.00 64.10
261 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 8.90 10.10
262 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 32.80 11.10
263 Sequent Research Limited, India Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 214.30 304.70
264 Sequent Research Limited, India Sequent Scientific Limited, India Holding Any other transaction Trade Receivable NA 0.00 25.20 21.70
265 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 4,928.20 3,394.40
266 Alivira Animal Health Limited, India Sequent Research Limited, India Fellow Subsidiary Any other transaction Non Current Borrowing NA 0.00 180.70 188.60
267 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Non Current Borrowing NA 0.00 39,494.30 42,968.30
268 Alivira Italia S.R.L. Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing NA 0.00 90.90 103.40
269 Alivira Italia S.R.L. Vila Vina Participacions S.L., Spain Fellow Subsidiary Any other transaction Non Current Borrowing NA 0.00 0.00 167.30
270 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, Ireland Holding Any other transaction Non Current Borrowing NA 0.00 10,281.30 11,166.90
271 Laboratorios Karizoo, S.A., Spain Phytotherapic Solutions S.L., Spain Fellow Subsidiary Any other transaction Non Current Borrowing NA 0.00 172.80 594.40
272 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Non Current Borrowing NA 0.00 742.40 793.10
273 Alivira Animal Health Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 12,358.40 13,502.50
274 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Loans and Advances NA 0.00 1,065.20 652.60
275 Phytotherapic Solutions S.L., Spain Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Loans and Advances NA 0.00 172.80 594.40
276 Sequent Research Limited, India Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Loans and Advances NA 0.00 180.70 188.60
277 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 39,494.30 42,968.30
278 Vila Vina Participacions S.L., Spain Alivira Italia S.R.L. Fellow Subsidiary Any other transaction Loans and Advances NA 0.00 0.00 167.30
279 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 742.40 793.10
280 Alivira Animal Health Limited, Ireland Sequent Scientific Limited, India Ultimate Holding company Any other transaction Trade Payable NA 0.00 0.00 13.90
281 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 0.00 125.00
282 Sequent Scientific Limited, India Alivira Animal Health Limited, Ireland Step down subsidiary Any other transaction Trade Receivable NA 0.00 13.40 13.90
283 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Loans and Advances NA 0.00 0.00 125.00
284 Alivira Animal Health Limited, India Sequent Scientific Limited, India Holding Any other transaction Loans and Advances NA 0.00 0.00 43.80
285 Alivira Animal Health Limited, Ireland Alivira Animal Health Limited, India Holding Any other transaction Current Borrowing NA 0.00 12,358.40 13,502.50
286 Alivira Animal Health Limited, Ireland Fendigo BV, Netherland Wholly owned subsidiary Any other transaction Current Borrowing NA 0.00 472.60 438.70
287 Alivira Animal Health Limited, Ireland N-Vet AB, Sweden Subsidiary Any other transaction Current Borrowing NA 0.00 117.10 131.90
288 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Any other transaction Current Borrowing NA 0.00 1,067.80 652.80
289 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Fellow Subsidiary Any other transaction Current Borrowing NA 0.00 4,109.50 4,433.80
290 Alivira Animal Health UK Limited Alivira Animal Health Limited, Ireland Holding Any other transaction Current Borrowing NA 0.00 28.80 44.80
291 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Current Borrowing NA 0.00 10,916.80 12,467.10
292 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Alivira Animal Health Limited, Ireland Holding Any other transaction Current Borrowing NA 0.00 5,447.80 5,784.30
293 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Current Borrowing NA 0.00 2,389.30 2,620.70
294 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Current Borrowing NA 0.00 0.00 926.00
295 Alivira Animal Health Limited, Ireland Alivira Italia S.R.L. Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 91.10 103.50
296 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Any other transaction Loans and Advances NA 0.00 4,090.00 4,437.20
297 Alivira Animal Health Limited, Ireland Alivira Saude Animal Brasil Participacoes Ltda Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 10,231.80 11,175.90
298 Alivira Animal Health Limited, Ireland Alivira Animal Health UK Limited Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 27.90 43.20
299 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 10,936.80 12,462.30
300 Alivira Animal Health Limited, Ireland Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 1,728.60 (1,686.90)
301 Alivira Animal Health Limited, Ireland Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Step down subsidiary Any other transaction Loans and Advances NA 0.00 2,403.40 2,624.20
302 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances NA 0.00 463.80 416.90
303 N-Vet AB, Sweden Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances NA 0.00 92.20 104.20
304 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 0.00 926.00
305 Sequent Scientific Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Trade Payable NA 0.00 0.00 0.20
306 Alivira Animal Health Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Trade Receivable NA 0.00 0.00 52.20
307 Alivira Animal Health Limited, India Symed Labs Limited Other related party Any other transaction Trade Receivable NA 0.00 0.00 86.30
308 Alivira Animal Health Limited, India Symed Labs Limited Other related party Any other transaction Trade Payable NA 0.00 74.90 292.80
309 Alivira Animal Health Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Trade Payable NA 0.00 24.70 40.70
310 Sequent Research Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Trade Payable NA 0.00 2.00 0.20
311 Sequent Research Limited, India Viyash Life Sciences Private Limited Other related party Any other transaction Trade Receivable NA 0.00 0.00 11.70
312 Viyash Life Sciences Private Limited Sequent Scientific Limited, India Other related party Any other transaction Trade Receivable NA 0.00 0.00 0.20
313 Viyash Life Sciences Private Limited Alivira Animal Health Limited, India Other related party Any other transaction Trade Payable NA 0.00 0.00 52.20
314 Symed Labs Limited Alivira Animal Health Limited, India Other related party Any other transaction Trade Payable NA 0.00 0.00 86.30
315 Symed Labs Limited Alivira Animal Health Limited, India Other related party Any other transaction Trade Receivable NA 0.00 0.00 292.80
316 Symed Labs Limited Alivira Animal Health Limited, India Other related party Any other transaction Trade Receivable NA 0.00 0.00 40.70
317 Viyash Life Sciences Private Limited Sequent Research Limited, India Other related party Any other transaction Trade Receivable NA 0.00 0.00 0.20
318 Viyash Life Sciences Private Limited Sequent Research Limited, India Other related party Any other transaction Trade Payable NA 0.00 0.00 11.70
319 Alivira Animal Health Limited, Ireland Bremer Pharma GmbH, Germany Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 0.00 0.00
320 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, Ireland Holding Any other transaction Advances from customers NA 0.00 0.00 0.00
321 N-Vet AB, Sweden Sequent Scientific Limited, India Ultimate Holding company Any other transaction Trade Receivable NA 0.00 76.60 0.00
322 Sequent Scientific Limited, India N-Vet AB, Sweden Step down subsidiary Any other transaction Trade Receivable NA 0.00 8.00 0.00
323 Alivira Animal Health Limited, Ireland Sequent Scientific Limited, India Ultimate Holding company Any other transaction Trade Payable NA 0.00 13.40 0.00
324 Alivira Saude Animal Ltda, Brazil Alivira Animal Health Limited, Ireland Fellow Subsidiary Any other transaction Trade Payable NA 0.00 1.50 0.00
325 Alivira Saude Animal Ltda, Brazil Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 8.40 0.00
326 Alivira Saude Animal Ltda, Brazil Phytotherapic Solutions S.L., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 0.00 0.00
327 Alivira Saude Animal Brasil Participacoes Ltda Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Trade Payable NA 0.00 17.50 0.00
328 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Trade Payable NA 0.00 0.00 0.00
329 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Any other transaction Trade Payable NA 0.00 10.60 0.00
330 Fendigo SA, Belgium Phytotherapic Solutions S.L., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 1.20 0.00
331 Fendigo BV, Netherland Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Payable NA 0.00 0.00 0.00
332 Laboratorios Karizoo, S.A., Spain Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Trade Payable NA 0.00 23.00 0.00
333 Laboratorios Karizoo, S.A., Spain Alivira Italia S.R.L. Fellow Subsidiary Any other transaction Trade Payable NA 0.00 0.20 0.00
334 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Trade Payable NA 0.00 0.00 0.00
335 N-Vet AB, Sweden Sequent Scientific Limited, India Ultimate Holding company Any other transaction Trade Payable NA 0.00 8.10 0.00
336 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Trade Payable NA 0.00 0.00 0.00
337 Phytotherapic Solutions S.L., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Trade Payable NA 0.00 0.00 0.00
338 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 0.00 0.00
339 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Trade Payable NA 0.00 0.00 0.00
340 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Any other transaction Trade Payable NA 0.00 0.00 0.00
341 Alivira Animal Health Limited, India Alivira Saude Animal Brasil Participacoes Ltda Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 17.10 0.00
342 Alivira Animal Health Limited, India Bremer Pharma GmbH, Germany Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 0.00 0.00
343 Alivira Animal Health Limited, India Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 23.20 0.00
344 Alivira Animal Health Limited, India Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 0.00 0.00
345 Alivira Animal Health Limited, Ireland Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 1.60 0.00
346 Alivira Animal Health Limited, Ireland Phytotherapic Solutions S.L., Spain Step down subsidiary Any other transaction Trade Receivable NA 0.00 0.00 0.00
347 Alivira Italia S.R.L. Laboratorios Karizoo, S.A., Spain Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 0.20 0.00
348 Bremer Pharma GmbH, Germany Alivira Animal Health Limited, India Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 3.30 0.00
349 Laboratorios Karizoo, S.A., Spain Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 8.40 0.00
350 Laboratorios Karizoo, S.A., Spain Fendigo BV, Netherland Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 0.00 0.00
351 Laboratorios Karizoo, S.A., Spain Vila Vina Participacions S.L., Spain Holding Any other transaction Trade Receivable NA 0.00 0.00 0.00
352 Phytotherapic Solutions S.L., Spain Alivira Saude Animal Ltda, Brazil Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 0.00 0.00
353 Phytotherapic Solutions S.L., Spain Fendigo SA, Belgium Fellow Subsidiary Any other transaction Trade Receivable NA 0.00 1.20 0.00
354 Sequent Scientific Limited, India Alivira Animal Health Limited, Ireland Step down subsidiary Any other transaction Trade Receivable NA 0.00 0.00 0.00
355 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Trade Receivable NA 0.00 0.00 0.00
356 Vila Vina Participacions S.L., Spain Laboratorios Karizoo, S.A., Spain Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 0.00 0.00
357 Vila Vina Participacions S.L., Spain Phytotherapic Solutions S.L., Spain Wholly owned subsidiary Any other transaction Trade Receivable NA 0.00 0.00 0.00
358 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 0.00 0.00
359 Fendigo BV, Netherland Alivira Animal Health Limited, Ireland Holding Any other transaction Trade Receivable NA 0.00 0.00 0.00
360 Phytotherapic Solutions S.L., Spain Alivira Animal Health Limited, Ireland Ultimate Holding company Any other transaction Interest Payable NA 0.00 0.00 0.00
361 Vila Vina Participacions S.L., Spain Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances NA 0.00 0.00 0.00
362 Vila Vina Participacions S.L., Spain Laboratorios Karizoo S.A. de C.V.,Mexico Subsidiary Any other transaction Loans and Advances NA 0.00 1.00 0.00
363 Sequent Scientific Limited, India N-Vet AB, Sweden Step down subsidiary Any other transaction Trade Payable NA 0.00 75.00 0.00
364 Bremer Pharma GmbH, Germany Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Fellow Subsidiary Any other transaction Purchase/sale of PPE NA 0.00 69.70 0.00
365 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Bremer Pharma GmbH, Germany Fellow Subsidiary Any other transaction Purchase/sale of PPE NA 0.00 60.70 0.00
366 Sequent Research Limited, India Sequent Scientific Limited, India Holding Any other transaction Purchase/sale of PPE NA 0.00 0.00 0.00
367 Sequent Scientific Limited, India Sequent Research Limited, India Wholly owned subsidiary Any other transaction Purchase/sale of PPE NA 0.00 0.00 0.00
368 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 101.50 0.00
369 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 81.30 0.00
370 Sequent Scientific Limited, India Sequent Research Limited, India Wholly owned subsidiary Any other transaction Loans and Advances NA 0.00 0.00 0.00
371 Alivira Animal Health Limited, Ireland Fendigo SA, Belgium Wholly owned subsidiary Any other transaction Current Borrowing NA 0.00 0.00 0.00
372 Alivira Animal Health Limited, Ireland Vila Vina Participacions S.L., Spain Subsidiary Any other transaction Current Borrowing NA 0.00 0.00 0.00
373 Alivira Saude Animal Brasil Participacoes Ltda Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Wholly owned subsidiary Any other transaction Current Borrowing NA 0.00 0.00 0.00
374 Laboratorios Karizoo S.A. de C.V.,Mexico Vila Vina Participacions S.L., Spain Holding Any other transaction Current Borrowing NA 0.00 1.00 0.00
375 Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Wholly owned subsidiary Any other transaction Current Borrowing NA 0.00 1,481.60 0.00
376 Evanvet Distribuidora De Produtos Veterinarios Ltda, Brazil Alivira Saude Animal Brasil Participacoes Ltda Holding Any other transaction Loans and Advances NA 0.00 0.00 0.00
377 Fendigo SA, Belgium Alivira Animal Health Limited, Ireland Holding Any other transaction Loans and Advances NA 0.00 0.00 0.00
378 Topkim Topkapi ilac premiks Sanayi Ve Ticaret A.S., Turkey Provet Veteriner Urunleri San.Ve Tic. A.S., Turkey Holding Any other transaction Loans and Advances NA 0.00 1,481.60 0.00
379 Sequent Scientific Limited, India Dr Kamal Sharma Independent Directors Any other transaction Director commission NA 0.00 10.00 0.00
380 Sequent Scientific Limited, India Milind Sarwate Independent Directors Any other transaction Director commission NA 0.00 13.00 1.00
381 Sequent Scientific Limited, India Dr. Kausalya Santhanam Independent Directors Any other transaction Director commission NA 0.00 3.00 0.00
382 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiaries Any other transaction Corporate guarantee given NA 0.00 17,368.20 26,500.00
383 Sequent Scientific Limited, India Alivira Animal Health Limited, Ireland Wholly owned subsidiaries Any other transaction Corporate guarantee given NA 0.00 24,818.60 24,818.60
384 Sequent Scientific Limited, India Alivira Animal Health Limited, India Wholly owned subsidiaries Any other transaction Corporate guarantee given NA 0.00 3,800.00 3,800.00
Total value of transaction during the reporting period 47,431.10